Biosysen Limited

SEHK:1355 Stock Report

Market Cap: HK$173.0m

Biosysen Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biosysen.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Hospitality earnings growth41.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article Mar 06

Estimating The Intrinsic Value Of Legend Strategy International Holdings Group Company Limited (HKG:1355)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Legend Strategy International Holdings Group fair value...
Analysis Article Jun 21

Returns On Capital Are Showing Encouraging Signs At Legend Strategy International Holdings Group (HKG:1355)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Analysis Article Apr 06

Legend Strategy International Holdings Group Company Limited (HKG:1355) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

The Legend Strategy International Holdings Group Company Limited ( HKG:1355 ) share price has fared very poorly over...
Analysis Article Feb 18

The Return Trends At Legend Strategy International Holdings Group (HKG:1355) Look Promising

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Analysis Article Oct 19

There's Been No Shortage Of Growth Recently For Legend Strategy International Holdings Group's (HKG:1355) Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Jun 26

Legend Strategy International Holdings Group (HKG:1355) Use Of Debt Could Be Considered Risky

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Apr 25

There's Been No Shortage Of Growth Recently For Legend Strategy International Holdings Group's (HKG:1355) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Analysis Article Mar 03

We Think Legend Strategy International Holdings Group (HKG:1355) Is Taking Some Risk With Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article Dec 12

Calculating The Intrinsic Value Of Legend Strategy International Holdings Group Company Limited (HKG:1355)

In this article we are going to estimate the intrinsic value of Legend Strategy International Holdings Group Company...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biosysen has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:1355 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202551-44-50-33N/A
9/30/202549-41-38-23N/A
6/30/202547-38-26-14N/A
3/31/202544-29-15N/A
12/31/202441-212424N/A
9/30/202448-253030N/A
6/30/202456-303636N/A
3/31/202462-343535N/A
12/31/202368-383535N/A
9/30/202365-222828N/A
6/30/202362-62121N/A
3/31/202362-71415N/A
12/31/202263-869N/A
9/30/202268-11620N/A
6/30/20227452531N/A
3/31/20227252031N/A
12/31/20217151430N/A
9/30/2021695028N/A
6/30/2021684-1525N/A
3/31/2021593-1122N/A
12/31/2020512-620N/A
9/30/202045-6318N/A
6/30/202039-141216N/A
3/31/202043-151015N/A
12/31/201946-15714N/A
9/30/201948-10N/A8N/A
6/30/201951-5N/A2N/A
3/31/201948-5N/A3N/A
12/31/201846-4N/A4N/A
9/30/201834-17N/A9N/A
6/30/201822-30N/A13N/A
3/31/201819-36N/A7N/A
12/31/201716-42N/A1N/A
9/30/201716-43N/A-1N/A
6/30/201716-45N/A-3N/A
3/31/201717-71N/A-27N/A
12/31/201618-98N/A-51N/A
9/30/201617-139N/A-67N/A
6/30/201616-180N/A-82N/A
3/31/201618-152N/A-60N/A
12/31/201520-124N/A-39N/A
9/30/201523-92N/A-22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1355's forecast earnings growth is above the savings rate (3%).

Earnings vs Market: Insufficient data to determine if 1355's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 1355's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1355's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 1355's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 1355's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 18:50
End of Day Share Price 2026/07/07 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biosysen Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.